Did Neuralink make the wrong bet?

Neuralink’s early brain-computer implants have mainly focused on cursor control, but speech restoration is now looking more promising.

As new research and competitors accelerate progress in speech BCIs, Neuralink has begun recruiting for speech restoration trials in the UAE and the U.S.

The company is using the same core hardware while targeting patients such as people with ALS, signaling a more medical-first direction.

The shift suggests Neuralink’s original consumer-style vision is giving way to a more practical use case, and the field is moving toward speech decoding as a faster path to patient benefit.